These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 312690)

  • 1. High dose methotrexate followed by citrovorum factor reversal in patients with advanced cancer.
    Ambinder EP; Perloff M; Ohnuma T; Biller HF; Holland JF
    Cancer; 1979 Apr; 43(4):1177-82. PubMed ID: 312690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic and clinical studies of 24-h infusions of high-dose methotrexate.
    Cohen HJ; Jaffe N
    Cancer Chemother Pharmacol; 1978; 1(1):61-4. PubMed ID: 373909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toxic and therapeutic effects of methotrexate-folinic acid (Leucovorin) in advanced cancer and leukemia.
    Vogler WR; Jacobs J
    Cancer; 1971 Oct; 28(4):894-901. PubMed ID: 5315548
    [No Abstract]   [Full Text] [Related]  

  • 4. High-dose methotrexate for the remission induction of refractory adult acute lymphocytic leukemia.
    Peterson BA; Bloomfield CD
    Med Pediatr Oncol; 1978; 5(1):79-84. PubMed ID: 370537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "Single"-agent activity of high-dose methotrexate with citrovorum factor rescue.
    Von Hoff DD; Rozencweig M; Louie AC; Bender RA; Muggia FM
    Cancer Treat Rep; 1978 Feb; 62(2):233-5. PubMed ID: 305823
    [No Abstract]   [Full Text] [Related]  

  • 6. A randomized comparison of high-dose infusion methotrexate versus standard-dose weekly therapy in head and neck squamous cancer.
    Taylor SG; McGuire WP; Hauck WW; Showel JL; Lad TE
    J Clin Oncol; 1984 Sep; 2(9):1006-11. PubMed ID: 6332178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II clinical trial with high-dose methotrexate therapy and citrovorum factor rescue.
    Isacoff WH; Eilber F; Tabbarah H; Klein P; Dollinger M; Lemkin S; Sheehy P; Cone L; Rosenbloom B; Sieger L; Block JB
    Cancer Treat Rep; 1978 Sep; 62(9):1295-304. PubMed ID: 356984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-dose methotrexate for osteosarcoma: toxicity and clinical results.
    Breithaupt H; Küenzlen E
    Oncology; 1983; 40(2):85-9. PubMed ID: 6600827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Moderate dose methotrexate with citrovorum factor rescue therapy in the treatment of head and neck cancer].
    Inuyama Y; Hiroto I; Taketa C; Horiuchi M; Mashino S; Fujii M; Matsuura S; Satake B; Takeoda S; Nishijima W; Okuda M; Sakaguchi K; Tanigaito Y; Imakirei M; Konno T; Hirokawa T; Takada K; Ono I; Saitoh H; Takemiya S; Shimada F; Omura K; Miyake H; Fujii K; Kawabe Y; Kondoh T; Komiyama S; Yanagida T; Matsumura Y; Hirano M; Araki S
    Gan To Kagaku Ryoho; 1982 Dec; 9(12):2193-200. PubMed ID: 6764099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progress report on high-dose methotrexate (NSC-740) with citrovorum rescue in the treatment of metastatic bone tumors.
    Jaffe N
    Cancer Chemother Rep; 1974; 58(2):275-80. PubMed ID: 4598245
    [No Abstract]   [Full Text] [Related]  

  • 11. High dose methotrexate with citrovorum factor in adult resistant lymphoma.
    Turman S; Coleman M; Silver RT; Pasmantier M
    Cancer; 1977 Dec; 40(6):2823-8. PubMed ID: 338137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-folate resistance in leukemia: treatment with "high-dose" methotrexate and citrovorum factor.
    Bender RA
    Cancer Treat Rev; 1975 Sep; 2(3):215-24. PubMed ID: 1104164
    [No Abstract]   [Full Text] [Related]  

  • 13. "Rescue" techniques in cancer chemotherapy: use of leucovorin and other rescue agents after methotrexate treatment.
    Bertino JR
    Semin Oncol; 1977 Jun; 4(2):203-16. PubMed ID: 301662
    [No Abstract]   [Full Text] [Related]  

  • 14. Multidrug chemotherapy in pulmonary treatment of osteosarcoma.
    Sutow WW; Gehan EA; Vietti TJ; Frias AE; Dyment PG
    J Bone Joint Surg Am; 1976 Jul; 58(5):629-33. PubMed ID: 1084348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of high-dose methotrexate with citrovorum factor on human granulopoiesis.
    Schremi W; Lohrmann HP
    Cancer Res; 1979 Oct; 39(10):4195-9. PubMed ID: 314330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Moderate-dose methotrexate in head and neck cancer.
    Advani SH; Mehta AR; Rao MR; Fakih AR; Sanghvi VD; Nair CN; Gopal R
    Oncology; 1981; 38(6):329-33. PubMed ID: 6975453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The biochemistry of the citrovorum factor rescue effect in normal bone marrow cells after high-dose methotrexate.
    Sauer H; Schalhorn A; Wilmanns W
    Eur J Cancer (1965); 1979 Oct; 15(10):1203-9. PubMed ID: 316389
    [No Abstract]   [Full Text] [Related]  

  • 18. [High-dose methotrexate with citrovorum factor rescue in the treatment of malignant tumors (author's transl)].
    Wang QL; Sun Y; Zhou JC; Song SZ; Lu L; Ye ZS
    Zhonghua Zhong Liu Za Zhi; 1979; 1(2):144-9. PubMed ID: 317948
    [No Abstract]   [Full Text] [Related]  

  • 19. Refractory acute leukaemia in adults treated with sequential colaspase and high-dose methotrexate.
    Yap BS; McCredie KB; Benjamin RS; Bodey GP; Freireich EJ
    Br Med J; 1978 Sep; 2(6140):791-3. PubMed ID: 279387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Essential laboratory determinations for monitoring high-dose methotrexate treatment with citrovorum factor rescue.
    Jürgens H; Ebell W; Bachmann R; Kupke I; Richter O; Andräs A; Göbel U
    Pediatr Pharmacol (New York); 1983; 3(3-4):157-65. PubMed ID: 6610851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.